Update on the use of melatonin in pediatrics

Eloisa Gitto, Salvatore Aversa, Russel J Reiter, Ignazio Barberi, Salvatore Pellegrino

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Melatonin, an endogenously produced indoleamine, is a highly effective antioxidant, free radical scavenger, and a primary circadian regulator. Melatonin has important antioxidant properties owing to direct and indirect effects. It directly scavenges reactive oxygen and reactive nitrogen species, prevents molecular oxidation, improves mitochondrial physiology, and restores glutathione homeostasis. Its indirect antioxidant effects stem from its ability to stimulate the activities of the enzymes involved in the glutathione cycling and production. Melatonin, by reducing free radical damage, may be an effective protective agent for the fetus as it is in adults. Several clinical studies on melatonin have shown that it reduces oxidative stress in human newborns with sepsis, hypoxic distress, or other conditions, where there is excessive free radical generation. A role of melatonin in infant development has also been suggested. Pineal dysfunction may be associated with deleterious outcomes in infants and may contribute to an increased prevalence of sudden infant death syndrome. Delayed melatonin production is evident in infants who had experienced an apparent life-threatening event. Melatonin has been used as a pharmacologic treatment for insomnias associated with shift work, jet lag, and delayed sleep onset in adults for decades. In children as well, melatonin has value as a sleep-promoting agent. Evidence suggests that melatonin has utility as an analgesic agent presumably related to its ability to release β-endorphin. The data support the notion that melatonin, or one of its analogs, might find use as an anesthetic agent in children.

Original languageEnglish (US)
Pages (from-to)21-28
Number of pages8
JournalJournal of Pineal Research
Volume50
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Melatonin
Pediatrics
Aptitude
Antioxidants
Free Radicals
Glutathione
Endorphins
Reactive Nitrogen Species
Protective Agents
Free Radical Scavengers
Sudden Infant Death
Child Development
Analgesics
Anesthetics
Sepsis
Sleep
Oxidative Stress
Fetus
Homeostasis
Newborn Infant

Keywords

  • antioxidant
  • children
  • clinical trials
  • free radicals
  • melatonin
  • sleep

ASJC Scopus subject areas

  • Endocrinology

Cite this

Update on the use of melatonin in pediatrics. / Gitto, Eloisa; Aversa, Salvatore; Reiter, Russel J; Barberi, Ignazio; Pellegrino, Salvatore.

In: Journal of Pineal Research, Vol. 50, No. 1, 01.2011, p. 21-28.

Research output: Contribution to journalArticle

Gitto, E, Aversa, S, Reiter, RJ, Barberi, I & Pellegrino, S 2011, 'Update on the use of melatonin in pediatrics', Journal of Pineal Research, vol. 50, no. 1, pp. 21-28. https://doi.org/10.1111/j.1600-079X.2010.00814.x
Gitto, Eloisa ; Aversa, Salvatore ; Reiter, Russel J ; Barberi, Ignazio ; Pellegrino, Salvatore. / Update on the use of melatonin in pediatrics. In: Journal of Pineal Research. 2011 ; Vol. 50, No. 1. pp. 21-28.
@article{3fcfa9f27b464cc7a547987b64cedb1c,
title = "Update on the use of melatonin in pediatrics",
abstract = "Melatonin, an endogenously produced indoleamine, is a highly effective antioxidant, free radical scavenger, and a primary circadian regulator. Melatonin has important antioxidant properties owing to direct and indirect effects. It directly scavenges reactive oxygen and reactive nitrogen species, prevents molecular oxidation, improves mitochondrial physiology, and restores glutathione homeostasis. Its indirect antioxidant effects stem from its ability to stimulate the activities of the enzymes involved in the glutathione cycling and production. Melatonin, by reducing free radical damage, may be an effective protective agent for the fetus as it is in adults. Several clinical studies on melatonin have shown that it reduces oxidative stress in human newborns with sepsis, hypoxic distress, or other conditions, where there is excessive free radical generation. A role of melatonin in infant development has also been suggested. Pineal dysfunction may be associated with deleterious outcomes in infants and may contribute to an increased prevalence of sudden infant death syndrome. Delayed melatonin production is evident in infants who had experienced an apparent life-threatening event. Melatonin has been used as a pharmacologic treatment for insomnias associated with shift work, jet lag, and delayed sleep onset in adults for decades. In children as well, melatonin has value as a sleep-promoting agent. Evidence suggests that melatonin has utility as an analgesic agent presumably related to its ability to release β-endorphin. The data support the notion that melatonin, or one of its analogs, might find use as an anesthetic agent in children.",
keywords = "antioxidant, children, clinical trials, free radicals, melatonin, sleep",
author = "Eloisa Gitto and Salvatore Aversa and Reiter, {Russel J} and Ignazio Barberi and Salvatore Pellegrino",
year = "2011",
month = "1",
doi = "10.1111/j.1600-079X.2010.00814.x",
language = "English (US)",
volume = "50",
pages = "21--28",
journal = "Journal of Pineal Research",
issn = "0742-3098",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Update on the use of melatonin in pediatrics

AU - Gitto, Eloisa

AU - Aversa, Salvatore

AU - Reiter, Russel J

AU - Barberi, Ignazio

AU - Pellegrino, Salvatore

PY - 2011/1

Y1 - 2011/1

N2 - Melatonin, an endogenously produced indoleamine, is a highly effective antioxidant, free radical scavenger, and a primary circadian regulator. Melatonin has important antioxidant properties owing to direct and indirect effects. It directly scavenges reactive oxygen and reactive nitrogen species, prevents molecular oxidation, improves mitochondrial physiology, and restores glutathione homeostasis. Its indirect antioxidant effects stem from its ability to stimulate the activities of the enzymes involved in the glutathione cycling and production. Melatonin, by reducing free radical damage, may be an effective protective agent for the fetus as it is in adults. Several clinical studies on melatonin have shown that it reduces oxidative stress in human newborns with sepsis, hypoxic distress, or other conditions, where there is excessive free radical generation. A role of melatonin in infant development has also been suggested. Pineal dysfunction may be associated with deleterious outcomes in infants and may contribute to an increased prevalence of sudden infant death syndrome. Delayed melatonin production is evident in infants who had experienced an apparent life-threatening event. Melatonin has been used as a pharmacologic treatment for insomnias associated with shift work, jet lag, and delayed sleep onset in adults for decades. In children as well, melatonin has value as a sleep-promoting agent. Evidence suggests that melatonin has utility as an analgesic agent presumably related to its ability to release β-endorphin. The data support the notion that melatonin, or one of its analogs, might find use as an anesthetic agent in children.

AB - Melatonin, an endogenously produced indoleamine, is a highly effective antioxidant, free radical scavenger, and a primary circadian regulator. Melatonin has important antioxidant properties owing to direct and indirect effects. It directly scavenges reactive oxygen and reactive nitrogen species, prevents molecular oxidation, improves mitochondrial physiology, and restores glutathione homeostasis. Its indirect antioxidant effects stem from its ability to stimulate the activities of the enzymes involved in the glutathione cycling and production. Melatonin, by reducing free radical damage, may be an effective protective agent for the fetus as it is in adults. Several clinical studies on melatonin have shown that it reduces oxidative stress in human newborns with sepsis, hypoxic distress, or other conditions, where there is excessive free radical generation. A role of melatonin in infant development has also been suggested. Pineal dysfunction may be associated with deleterious outcomes in infants and may contribute to an increased prevalence of sudden infant death syndrome. Delayed melatonin production is evident in infants who had experienced an apparent life-threatening event. Melatonin has been used as a pharmacologic treatment for insomnias associated with shift work, jet lag, and delayed sleep onset in adults for decades. In children as well, melatonin has value as a sleep-promoting agent. Evidence suggests that melatonin has utility as an analgesic agent presumably related to its ability to release β-endorphin. The data support the notion that melatonin, or one of its analogs, might find use as an anesthetic agent in children.

KW - antioxidant

KW - children

KW - clinical trials

KW - free radicals

KW - melatonin

KW - sleep

UR - http://www.scopus.com/inward/record.url?scp=78650144741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650144741&partnerID=8YFLogxK

U2 - 10.1111/j.1600-079X.2010.00814.x

DO - 10.1111/j.1600-079X.2010.00814.x

M3 - Article

VL - 50

SP - 21

EP - 28

JO - Journal of Pineal Research

JF - Journal of Pineal Research

SN - 0742-3098

IS - 1

ER -